The company said shareholders elected Sangeeta Bhatia, Lloyd Carney and others as directors at its annual meeting held on May 15, 2024, to serve until the 2025 annual meeting. Bruce Sachs received 207,616,033 votes for and 14,397,759 votes against.

1. 01

   The company said shareholders elected Sangeeta Bhatia, Lloyd Carney and others as directors at its annual meeting held on May 15, 2024, to serve until the 2025 annual meeting. Bruce Sachs received 207,616,033 votes for and 14,397,759 votes against.

2. 02

   Vertex Pharmaceuticals said shareholders approved the selection of Ernst & Young LLP as the independent outside auditor for the fiscal year ending December 31, 2024. The vote was 229,460,523 for, 3,987,619 against and 290,126 abstentions.

3. 03

   The company said shareholders approved, on an advisory basis, the 2023 compensation program for its named executive officers. The vote was 202,098,575 for, 19,223,784 against and 875,760 abstentions.

4. 04

   The company said a shareholder proposal on a special shareholder meeting improvement was approved with 160,438,357 votes for and 61,494,550 against. A shareholder proposal for a report on racial and gender pay gaps was not approved, with 63,865,687 votes for and 157,637,997 against.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.